UK markets closed
NIKKEI 225
38,617.10 -329.83 (-0.85%) HANG SENG
19,195.60 -25.02 (-0.13%) CRUDE OIL
77.79 -0.87 (-1.11%) GOLD FUTURES
2,391.60 -34.30 (-1.41%) DOW
39,725.13 -147.86 (-0.37%) Bitcoin GBP
54,864.95 +57.88 (+0.11%)
Beximco Pharmaceuticals Limited (BXP.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 02:05PM BST
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 329.81M |
| Enterprise value | 369.97M |
| Trailing P/E | 5.12 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.63 |
| Price/book (mrq) | 0.59 |
| Enterprise value/revenue | 1.30 |
| Enterprise value/EBITDA | 6.94 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.63 |
| 52-week change 3 | 3.85% |
| S&P500 52-week change 3 | 29.31% |
| 52-week high 3 | 45.00 |
| 52-week low 3 | 33.30 |
| 50-day moving average 3 | 38.00 |
| 200-day moving average 3 | 39.08 |
Share statistics
| Avg vol (3-month) 3 | 44.33k |
| Avg vol (10-day) 3 | 56.2k |
| Shares outstanding 5 | 446.11M |
| Implied shares outstanding 6 | 814.34M |
| Float 8 | 297.32M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 1.72% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.03 |
| Forward annual dividend yield 4 | 6.21% |
| Trailing annual dividend rate 3 | 3.50 |
| Trailing annual dividend yield 3 | 8.64% |
| 5-year average dividend yield 4 | 3.83 |
| Payout ratio 4 | 29.75% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 10 Nov 2023 |
| Last split factor 2 | 110:100 |
| Last split date 3 | 23 Nov 2020 |
Financial highlights
Currency in BDT.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 12.37% |
| Operating margin (ttm) | 17.20% |
Management effectiveness
| Return on assets (ttm) | 6.97% |
| Return on equity (ttm) | 10.99% |
Income statement
| Revenue (ttm) | 43.08B |
| Revenue per share (ttm) | 96.58 |
| Quarterly revenue growth (yoy) | 15.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.44B |
| Net income avi to common (ttm) | 5.33B |
| Diluted EPS (ttm) | 0.08 |
| Quarterly earnings growth (yoy) | 43.50% |
Balance sheet
| Total cash (mrq) | 1.73B |
| Total cash per share (mrq) | 3.88 |
| Total debt (mrq) | 7.43B |
| Total debt/equity (mrq) | 14.73% |
| Current ratio (mrq) | 1.80 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | 8.37B |
| Levered free cash flow (ttm) | 4.42B |
© 2024 Yahoo. All rights reserved.